BRIEF-Dexcom Reports Preliminary, Unaudited Q4 Revenue

Jan 10 (Reuters) - Dexcom Inc (DXCM):

* DEXCOM REPORTS PRELIMINARY, UNAUDITED REVENUE FOR THE FOURTH QUARTER 2021 AND SUMMARY DATA FROM THE DEXCOM G7 U.S. PIVOTAL TRIAL

* EXPECTS PRELIMINARY, UNAUDITED REVENUE FOR Q4 ENDED DECEMBER 31, 2021 TO BE ABOUT $698 MILLION

* FOR 2022, ANTICIPATES TOTAL REVENUE OF ABOUT $2.82 BILLION TO $2.94 BILLION

* FOR FISCAL 2021, TOTAL PRELIMINARY, UNAUDITED REVENUE IS EXPECTED TO BE ABOUT $2.448 BILLION

* Q4 REVENUE VIEW $696.5 MILLION -- REFINITIV IBES DATA

* FY2022 REVENUE VIEW $2.99 BILLION -- REFINITIV IBES DATA Source text for Eikon: Further company coverage: